Xylene neo nasal spray with camphor and menthol 0.1%, 15 ml

$5.46

Xylene neo nasal spray with camphor and menthol 0.1%, 15 ml

Quantity:

SKU: 01717195005 Categories: , , Tags: ,

Description

Composition
Active substance:
Xylometazoline hydrochloride – 0.100g
Excipients:
benzyl alcohol – 0.250 g Benzalkonium chloride – 0.010 g disodium edetate dihydrate (Trilon B) – 0.015 g, camphor racemic (camphor synthetic) – 0.005 g, levomenthol – 0.008 g Povidone K-17 – 0.250 g microcrystalline cellulose and carmellose sodium – 4.000 g macrogol 400 – 21,500 g, sodium dihydrogen phosphate dihydrate – 0,750 g disodium hydrogen phosphate dodecahydrate (in terms of 100% substance) – 0.150 g purified water – 100.0 g
Description:
Opaque, white gelatinous or liquid mass with a very faint odor of menthol and camphor and thixotropic properties (thickens in resting and diluted with shaking), which is located in a vial, sealed with metering pump, spray nozzle stocked with a protective cap. The drug is dispensed from the vial through the nozzle spray in the form of an aerosol cloud, which is the dispersed particles in a gaseous medium of a viscous liquid.
Product form:
Nasal spray with camphor and menthol flavor, 0.1%
15 g glass vials of glass lighting screw neck.
Each vial capped metering pump. Components of the metering pump are made of polyoxymethylene, low density polyethylene, polypropylene and stainless steel. The metering pump is provided with a nozzle-sprayer for nasal injection in polypropylene with a protective cap of low density polyethylene.
Each vial is a sealed metering pump, together with the spray nozzle and protective cap, as well as instructions for medical application is placed in a pile of cardboard.
Contraindications
Hypersensitivity to Xylometazoline or any other component of the preparation, hypertension, tachycardia, expressed atherosclerosis, glaucoma, atrophic rhinitis, surgical interventions in the meninges (disease), inflammatory diseases of the skin or mucosal nasal vestibule, hyperthyroidism, post transsphenoidal hypophysectomy, pregnancy , children under 6 years.
Not suitable for therapy inhibitors of monoamine oxidase (MAO) (including 14 days after withdrawal), and tricyclic and tetracyclic antidepressants, other local vasoconstrictive agents (decongestants) and with other drugs that increase blood pressure.
Carefully
Diabetes, prostate hyperplasia, breastfeeding, diseases of the circulatory system, including ischemic heart disease (angina), porphyria, pheochromocytoma, patients with hypersensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.
Dosage
1 mg / ml
Indications
Acute respiratory illness with symptoms of rhinitis (common cold), acute allergic rhinitis, sinusitis, hay fever; evstahiit, otitis media (in combination therapy to reduce the nasopharyngeal mucosa edema); Preparing the patient for diagnostic procedures in the nasal passages.
Interaction with other drugs
Simultaneous application Xylometazoline with monoamine oxidase inhibitors (MAOIs) and tricyclic and tetracyclic antidepressants may lead to increased blood pressure.
Overdose
Symptoms: an overdose or accidentally taking the drug inside may develop the following symptoms: nausea, vomiting, cyanosis, fever, a significant decrease in body temperature, dizziness, increased sweating, headache, bradycardia, tachycardia, arrhythmia, increased blood pressure, after which can develop lowering blood pressure, dizziness, respiratory depression, coma, convulsions. Young children are often observed with an overdose of a dominant central effects with seizures, coma, and bradycardia, apnea.
Treatment: symptoms, the patient should be monitored for a few hours. Accidental ingestion – gastric lavage, administration of activated charcoal.
pharmachologic effect
Pharmacological group:
decongestant agent – alpha-agonists
ATC code: R01AA07
Pharmacodynamics:
Xylometazoline refers to a group of local vasoconstrictive agents (decongestants) with alpha-Adrenomimeticalkie activity. Preparation facilitates nasal breathing by reducing edema and hyperemia of the nasal mucosa, and enhances the discharge of secretions. Relieves nasal breathing in rhinitis.
Effect of the drug occurs within a few minutes after its application. After introduction into the nasal cavity through excipients its viscosity increases, it is delayed in the mucosa of the nasal cavity, not extending to the lower respiratory tract, and retains activity. Due to this drug works to 24 hours.
Pharmacokinetics:
When applied topically, practically not absorbed, the plasma concentrations are so small that they can not identify with modern analytical methods.
Pregnancy and breast-feeding
During pregnancy, the use of the drug is contraindicated.
During the period of breast-feeding use of the drug is possible only if the potential benefit to the mother outweighs the potential risk to the child.
Conditions of supply of pharmacies
Without prescription
side effects
The classification of the frequency of occurrence of adverse reactions: very often (> 1/10), often (> 1/100 and
special instructions
Before use, clean the nasal passages.
You should not use more than 5-7 days. Long-term use (more than 7 days) can lead to reactive hyperemia nasal mucosa and atrophy of nasal mucosa. Do not exceed the recommended dose. Benzalkonium chloride, part of the drug may cause irritation and swelling of the nasal mucosa. Avoid getting product in eyes.
The effect on the ability to operate vehicles, machinery
In the application of xylometazoline in doses exceeding recommended, we can not exclude a violation of view, the possibility of systemic effects on the cardiovascular system. With the possible deterioration of the ability to drive vehicles, machinery. Use caution when driving, mechanisms.
Storage conditions
At a temperature of 15 to 25 ° C. Do not refrigerate or freeze.
Keep out of the reach of children.
Dosing and Administration
Intranasally.
Before each use, should be vigorously shaken bottle. Remove the protecting cap. Before the first use of the dispensing device multiple times to press it until the aerosol cloud. Insert tip into the nostril and press the dispensing device, thus making a deep breath nose, it is not necessary to throw back his head back. Then repeat the procedure by inserting the tip into the other nostril. After use, wipe clean the tip and close the bottle cap protects.
Drug appoint 1 injection in each nostril 1-2 times a day.
Do not use the drug over 5-7 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

xylene

There are no reviews yet.

Add your review